The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
Bangladesh · Delayed Price · Currency is BDT 307.50
+0.60 (0.20%)
At close: May 6, 2026
DSE:IBNSINA Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 788.34 | 633.19 | 670.52 | - | 605.87 | 489.12 |
Depreciation & Amortization | 216.47 | 210.36 | 203.11 | 764.54 | 223.93 | 215.86 |
Loss (Gain) From Sale of Assets | - | - | -0.36 | 11.15 | - | 1.22 |
Loss (Gain) on Equity Investments | - | - | - | -11.91 | 1.29 | 1.93 |
Other Operating Activities | -119.75 | -63.56 | -29.79 | 52.15 | -61.17 | -0.06 |
Change in Accounts Receivable | -20.29 | -20.29 | -46.97 | -66.51 | -26.55 | -1.93 |
Change in Inventory | -222.74 | -222.74 | -428.7 | -3.15 | -225.4 | -138.78 |
Change in Accounts Payable | 234.18 | 234.18 | -22.01 | 141.75 | -95.77 | -10.05 |
Change in Other Net Operating Assets | -47.47 | -47.47 | 44.11 | 10.16 | -3.62 | -5.14 |
Operating Cash Flow | 828.75 | 723.68 | 389.91 | 898.18 | 418.56 | 552.17 |
Operating Cash Flow Growth | 14.61% | 85.60% | -56.59% | 114.59% | -24.20% | 10.98% |
Capital Expenditures | -2,554 | -981.5 | -946.81 | -425.19 | -365.16 | -242.53 |
Sale of Property, Plant & Equipment | - | - | 0.42 | 2.55 | - | 1.43 |
Investment in Securities | 57.77 | 142.99 | -67 | -196.36 | 60 | -3 |
Other Investing Activities | 6.2 | 9.67 | 8.21 | 2.51 | 2.86 | 2.07 |
Investing Cash Flow | -2,490 | -828.84 | -1,005 | -616.49 | -302.3 | -242.03 |
Short-Term Debt Issued | - | - | 720.5 | - | 159.44 | - |
Long-Term Debt Issued | - | 444.21 | 200.4 | - | - | 171.7 |
Total Debt Issued | 1,576 | 444.21 | 920.9 | - | 159.44 | 171.7 |
Short-Term Debt Repaid | - | -231.73 | - | -137.72 | - | -272.31 |
Long-Term Debt Repaid | - | - | - | -37.92 | -51.61 | - |
Total Debt Repaid | 181.19 | -231.73 | - | -175.64 | -51.61 | -272.31 |
Net Debt Issued (Repaid) | 1,757 | 212.49 | 920.9 | -175.64 | 107.82 | -100.61 |
Common Dividends Paid | -224.29 | -193.87 | -179.9 | -178.52 | -177.39 | -131.51 |
Other Financing Activities | 60 | 35 | - | - | 17.5 | 3.5 |
Financing Cash Flow | 1,593 | 53.62 | 741 | -354.16 | -52.07 | -228.62 |
Foreign Exchange Rate Adjustments | 9.79 | 1.22 | 7.26 | 11.15 | -2.83 | -0.2 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | 0 | 0 | - |
Net Cash Flow | -58.71 | -50.33 | 133 | -61.32 | 61.37 | 81.32 |
Free Cash Flow | -1,725 | -257.82 | -556.9 | 472.99 | 53.4 | 309.64 |
Free Cash Flow Growth | - | - | - | 785.74% | -82.75% | - |
Free Cash Flow Margin | -12.80% | -2.17% | -4.90% | 5.18% | 0.63% | 4.20% |
Free Cash Flow Per Share | -55.22 | -8.25 | -17.82 | 15.14 | 1.71 | 9.91 |
Cash Interest Paid | 83.71 | 83.71 | 47.77 | 36.61 | 40.94 | 38.76 |
Cash Income Tax Paid | 180.79 | 180.67 | 203.58 | 131.83 | 216.77 | 186.64 |
Levered Free Cash Flow | -1,810 | -289.52 | -556.67 | 870.9 | 12.31 | 230.82 |
Unlevered Free Cash Flow | -1,736 | -234.89 | -523.18 | 898.67 | 41.89 | 255.82 |
Change in Working Capital | -56.31 | -56.31 | -453.57 | 82.25 | -351.35 | -155.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.